Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to ...

When the truth is doctored, lives hang in the balance.

What’s happening to our planet is having an undeniable and devastating impact across every aspect of human health. What harms ...

When we investigate millennial healthcare professionals (HCPs), we see a generation experiencing a clash of two existences.

Discover how AI, analytics and real-world data are reshaping Medical Affairs. Explore how AI, advanced analytics, and expanding access to real-world data are transforming Medical Affairs into a more ...

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Bristol Myers Squibb (BMS) has evolved its Standing in the Gaap programme by launching one of the largest multiple myeloma (MM) surveys ever conducted in the US. Designed to help identify the factors ...

One-carbon Therapeutics has partnered with Tempus AI to advance the clinical development of TH9619, a small molecule inhibitor of overexpressed enzymes in cancer cells. One-carbon Therapeutics, ...

Eli Lilly (Lilly) has agreee to acquire Centessa Pharmaceuticals in a deal worth up to $7.8bn. Centessa is a clinical-stage company focused on developing treatments for excessive daytime sleepiness ...

Novo Nordisk’s Awiqli (insulin icodec) has been approved by the US FDA as the first and only once-weekly, long-acting basal ...

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and ...